Lancashire and South Cumbria
Formulary
Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-04-02 Urinary incontinence
| Solifenacin |
|
Formulary
|
Tablets 5mg, 10mg Urinary frequency, urgency, and incontinence. First line pharmacological therapy for urinary frequency, urgency, incontinence in women. |
|
| Tolterodine |
|
Formulary
|
Tablets 1mg, 2mg, Modified-release capsules 4mg Urinary frequency, urgency, and incontinence. |
|
|
| Trospium |
|
Formulary
|
Tablets 20mg, Modified-release capsules 60mg Urinary frequency, urgency, and incontinence. |
|
|
| Mirabegron Betmiga® |
|
Formulary
|
Modified-release tablets 25mg, 50mg Urinary frequency, urgency, and incontinence. |
 MHRA: Mirabegron (Betmiga▼): risk of severe hypertension and associated cerebrovascular and cardiac events NICE TA290: Mirabegron for treating symptoms of overactive bladder |
|
|
| Oxybutynin |
|
Formulary
|
Tablets 2.5mg, 5mg Urinary frequency, urgency, and incontinence. |
|
|
| Darifenacin |
|
Formulary
|
Modified-release tablets 7.5mg, 15mg Urinary frequency, urgency, and incontinence. |
|
|
Links
- FSRH Clinical Guideline: Contraceptive Choices for Young People
- FSRH: Standards & Guidance
- FSRH: UK Medical Eligibility Criteria for Contraceptive Use (UKMEC)
LSCMMG: Primary Care Management of Erectile Dysfunction- LSCMMG: Primary Care Management of Overactive Bladder in Female Adults
- MHRA: Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
- MHRA: Mirabegron (Betmiga▼): risk of severe hypertension and associated cerebrovascular and cardiac events
- NICE CG30: Long-acting reversible contraception
- NICE CG97: Lower urinary tract symptoms in men: management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG194: Postnatal care
- NICE NG210: Pelvic floor dysfunction: prevention and non-surgical management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- NICE NG88: Heavy menstrual bleeding: assessment and management
- NICE TA290: Mirabegron for treating symptoms of overactive bladder
- NICE: TA290 - Mirabegron for overactive bladder